Underlying conditions within the defined six-week window of 30 days before to 14 days after first documented eculizumab treatment among eculizumab recipients in the IBM Marketscan Commercial Database, 2007–2017.
收藏数据链接：
官方服务：
资源简介：
Underlying conditions within the defined six-week window of 30 days before to 14 days after first documented eculizumab treatment among eculizumab recipients in the IBM Marketscan Commercial Database, 2007–2017.
创建时间：
2020-11-12
